Role of novel drug delivery system in enhancing iron bioavailability and reducing gastrointestinal side effects in iron deficiency anemia

Novel drug delivery systems represent a transformative approach in iron supplementation therapy, overcoming the dual challenges of poor bioavailability and gastrointestinal intolerance. By optimizing delivery, absorption, and release kinetics, these systems enhance therapeutic efficacy and patient acceptability. Ongoing research and clinical trials of such technologies hold great promise for developing next-generation iron formulations with enhanced bioavailability, superior safety, and effectiveness profiles.